docetaxel anhydrous has been researched along with Nasopharyngeal Carcinoma in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (1.64) | 29.6817 |
| 2010's | 44 (72.13) | 24.3611 |
| 2020's | 16 (26.23) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Li, S | 1 |
| Dong, G; Li, G; Liu, H; Liu, T; Wang, G; Wu, X; Xu, L; Zhan, J | 1 |
| Bai, YH; Du, KP; He, F; Li, JF; Liu, H; Liu, R; Lu, ZQ; Shi, QY; Tao, HY; Wang, ZL; Zhang, JJ | 1 |
| Colevas, AD; Coty, J; Hara, W; Jun, M; Le, QT; Lira, R; Lu, R; McMillan, A; Pinto, H; Quon, A; Winters, E | 1 |
| Lian, CL; Wu, SG; Zhou, P; Zhou, R; Zhou, Y | 1 |
| Ai, P; Chen, N; Duan, B; Li, Y; Shi, H; Tian, J; Zhu, J | 1 |
| Chen, D; Gao, J; Huang, C; Huang, H; Liang, J; Liu, M; Liu, W; Lu, Y; Luo, Z; Ning, X; Wang, R | 1 |
| Fan, WJ; Lu, YP; Luo, YR; Ma, L; Teng, F; Yu, W; Zhang, Q | 1 |
| He, Q; He, S; Hong, X; Lei, Y; Li, J; Li, Q; Li, Y; Liang, Y; Liu, N; Ma, J; Wang, Y; Yang, X; Zhang, P; Zhao, Y | 1 |
| Huang, J; Li, Q; Liao, W; Wu, Q; Zhang, N; Zhang, P | 1 |
| Chen, XX; Gan, JY; Gong, XY; Jiang, H; Jin, F; Li, YY; Liu, KQ; Liu, LN; Long, JH; Luo, XL; Wu, WL; Zhou, JJ | 1 |
| Li, C; Luo, S; Shi, M; Wang, J; Xu, M; Zang, J; Zhao, L | 1 |
| Chen, K; Li, Y; Nong, S; Pan, X; Zhu, X | 1 |
| Honma, Y; Ikeda, A; Itami, J; Ito, K; Kashihara, T; Kato, K; Kobayashi, K; Kubo, Y; Matsumoto, F; Mori, T; Murakami, N; Oka, H; Omura, G; Takamizawa, S; Yamamoto, S; Yoshimoto, S | 1 |
| An, X; Feng, K; Li, S; Liao, H; Mei, T; Zhan, J; Zhao, C | 1 |
| Li, S; Shen, L | 1 |
| Liao, K; Qiu, WZ; Tao, HY; Yuan, YW; Zhan, ZJ; Zheng, RH | 1 |
| Hamauchi, S; Iida, Y; Kamijo, T; Kawahira, M; Nishimura, T; Ogawa, H; Onitsuka, T; Onoe, T; Onozawa, Y; Yasui, H; Yokota, T | 1 |
| Chen, L; Guo, R; Li, WF; Lin, AH; Liu, X; Ma, J; Mao, YP; Sun, Y; Tang, LL; Xu, C; Yang, SP; Zhang, Y; Zhou, GQ | 1 |
| Hou, X; Jiang, G; Liu, T; Wang, Y; Wu, T; Wu, X; Xie, H; Xie, M | 1 |
| Alfonsi, M; Auperin, A; Blanchard, P; Bourhis, J; Cornely, A; Daoud, J; Elloumi, F; Frikha, M; Guigay, J; Lang, P; Moussa, A; Racadot, S; Sun, S; Tao, Y; Thariat, J; Toumi, N; Tuchais, C | 1 |
| He, X; Hu, C; Xue, F | 1 |
| Chan, LLK; Kam, MKM; Kwong, DLW; Lee, AWM; Lung, ML; Ng, WT; Ngan, RKC; Sze, HCK; Tung, SY; Yiu, HHY; Yuen, KT | 1 |
| Chen, J; Chen, QQ; Liu, X; Peng, XH; Peng, XY; Qi, J; Tan, JJ; Wang, F; Yu, B; Zeng, FF | 1 |
| Hu, C; Li, Y; Lu, X; Qian, W; Xu, T | 1 |
| Du, X; He, Q; Hong, X; Lei, Y; Li, Y; Liu, N; Ma, J; Sun, Y; Tang, X; Wang, Y; Wen, X; Yang, X; Zhang, J; Zhang, P | 1 |
| Chang, H; Deng, X; Ge, Y; Li, Y; Lu, L; OuYang, PY; Sheng, Y; Wu, JQ; Xie, T; Zhang, G | 1 |
| Chen, QY; Guo, L; Guo, SS; Li, XY; Liang, YJ; Lin, C; Lin, HX; Liu, LT; Liu, SL; Mai, HQ; Sun, XS; Tang, LQ; Tang, QN; Wen, YF; Xie, HJ; Yan, JJ; Yang, ZC | 1 |
| Li, N; Luo, J; Peng, X; Wei, Z; Zhang, Z | 1 |
| Chen, X; Liu, Y; Wang, Y; Zhang, T; Zhou, R; Zhu, J | 1 |
| Chen, S; Li, G; Li, J; Liu, T; Lu, Z; Wu, X; Zhang, S | 1 |
| Chen, G; Dai, J; Wang, XY; Xie, CH; Zeng, L; Zhong, YH; Zhou, YF | 1 |
| Gu, K; Hu, QC; Wang, JP; Wu, YW; Zhai, XM; Zhang, JN | 1 |
| Chen, X; Chew, SC; Chowbay, B; Lee, EJ; Lim, J; Singh, O; Tan, EH | 1 |
| Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Wang, XX | 1 |
| Guo, CY; Han, SH; Song, HP; Yu, L; Zhang, PJ; Zhang, Z | 1 |
| Chen, J; Du, C; Hu, C; Jiang, J; Liu, C; Wang, X; Ying, H; Zhou, J | 1 |
| Huang, SM; Li, JX; Lu, TX; Wen, BX | 1 |
| Chen, LK; Hu, ZH; Huang, Y; Liu, JL; Ma, Y; Ma, YX; Wei, CL; Wu, X; Xu, F; Xue, C; Zhang, J; Zhang, JW; Zhang, L; Zhao, HY; Zhao, LP; Zhao, YY; Zou, BY | 1 |
| Cheng, PJ; Li, P; Shan, GP; Zhang, L | 1 |
| Li, J; Liang, H; Pan, F; Pang, X; Ruan, Z; Zhang, Y; Zou, L | 1 |
| Arai, Y; Komatsu, M; Nishimura, G; Oridate, N; Sakuma, Y; Sano, D; Shiono, O; Taguchi, T; Takahashi, M; Yabuki, K | 1 |
| Casanova, M; Errihani, H; Ferrari, A; Grzegorzewski, KJ; Orbach, D; Özyar, E; Pan, J; Patte, C; Shen, L; Varan, A; Veyrat-Follet, C; Zhang, L | 1 |
| Cheng, ZB; Liao, H; Lin, Z; Liu, YM; Lv, BJ; Peng, PJ; Tang, C; Wang, SY; Wang, ZH | 1 |
| Bi, T; Gong, X; He, Q; Jin, F; Li, Y; Li, Z; Long, J; Luo, X; Qu, B; Wu, W | 1 |
| Bonanno, L; Caminiti, F; Cammaroto, G; De Salvo, S; Galletti, B; Galletti, F; Mannella, VK; Santoro, R | 1 |
| Du, L; Ma, L; Wang, Q; Yang, S; Zhang, X; Zhao, F | 1 |
| Chen, J; Lin, S; Yang, S; Zhang, S | 1 |
| Jiang, G; Liu, F; Liu, T; Wang, W; Wang, Y; Wu, T; Wu, X; Xie, M; Zhang, T | 1 |
| Ai, P; Gong, FM; Hu, X; Peng, X; Ren, M; Tang, J; Wu, S | 1 |
| Bei, JX; Cao, KJ; Chen, MY; Chen, QY; Guo, L; Guo, SS; Guo, X; Hong, MH; Liu, LT; Liu, XW; Ma, J; Mai, HQ; Mo, HY; Qian, CN; Shao, JY; Sun, Y; Tang, LQ; Xie, CM; Zeng, MS; Zhang, L; Zhao, C | 1 |
| Ai, J; Hou, M; Li, W; Liu, H; Tan, G; Xie, Z; Zeng, R | 1 |
| Blanchard, P; De Felice, F; Deutsch, E; El Khoury, C; Even, C; Gorphe, P; Janot, F; Levy, A; Nguyen, F; Ou, D; Tao, Y; Temam, S | 1 |
| Jiang, W; Luo, S; Pan, H; Shi, M; Wang, J; Xu, M; Zang, J; Zhao, L; Zhou, Y | 1 |
| Chen, L; Ma, J; Mao, YP; Sun, Y; Tang, LL; Yao, JJ; Yu, XL; Zhang, F; Zhang, WJ; Zhou, GQ | 1 |
| Hu, WH; Li, JS; Peng, M; Qi, SN; Xie, FY; Zou, GR | 1 |
| Ang, MK; Chowbay, B; Gao, F; Leong, SS; Lim, WT; Ngeow, J; Tan, EH; Toh, CK | 1 |
| Huang, Q; Li, DJ; Lu, MQ; Ren, JH; Su, J; Wu, YP; Xu, XH; Xue, F; Yi, F | 1 |
| Hirama, M; Horiuchi, C; Ishitoya, J; Komatsu, M; Matsuda, H; Mori, M; Niho, T; Nishimura, G; Sakuma, Y; Shiono, O; Taguch, T; Takahashi, M; Tsukuda, M | 1 |
| Du, C; Hu, C; Ying, H; Zhang, Y; Zhou, J | 1 |
| Cai, XY; Deng, YM; Feng, WN; Huang, ZL; Lin, L; Lu, QX; Wei, WH; Wu, YF; Xu, T; Zhang, GY | 1 |
1 review(s) available for docetaxel anhydrous and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Cisplatin; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Survival Analysis | 2020 |
20 trial(s) available for docetaxel anhydrous and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter rando
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Tolerance; Female; Fluorouracil; Humans; Induction Chemotherapy; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Young Adult | 2019 |
Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Follow-Up Studies; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prospective Studies; Radiation Injuries; Radiotherapy, Intensity-Modulated; Salivary Glands; Salivation; Xerostomia; Young Adult | 2020 |
[Analysis of follow-up results of chrono-chemotherapy or conventional chemotherapy combined with intensity modulated radiotherapy in locally advanced nasopharyngeal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Chronotherapy; Fluorouracil; Follow-Up Studies; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Radiotherapy, Intensity-Modulated; Treatment Outcome | 2020 |
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2018 |
Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.
Topics: Adult; Aged; Carcinoma; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Prognosis; Radiotherapy, Intensity-Modulated; Survival Analysis; Taxoids; Treatment Outcome; Tumor Burden; Young Adult | 2018 |
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Neoplasm Recurrence, Local; Progression-Free Survival; Prospective Studies; Radiotherapy, Intensity-Modulated; Salvage Therapy; Temporal Lobe; Treatment Outcome | 2018 |
Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Taxoids; Young Adult | 2013 |
Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Asian People; Carcinoma; Constitutive Androstane Receptor; Docetaxel; Female; Haplotypes; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platelet Count; Polymorphism, Single Nucleotide; Receptors, Cytoplasmic and Nuclear; Taxoids | 2014 |
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deoxycytidine; Disease-Free Survival; DNA, Viral; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Herpesvirus 4, Human; Humans; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2014 |
[Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukopenia; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mucositis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Remission Induction; Survival Rate; Taxoids; Vinblastine; Vinorelbine; Young Adult | 2013 |
Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Radiography; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Taxoids; Vascular Endothelial Growth Factor A | 2014 |
The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Prognosis; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome; Young Adult | 2015 |
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies; Taxoids; Young Adult | 2015 |
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Child; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Male; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Taxoids; Treatment Outcome | 2016 |
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Drug Design; Female; Humans; Injections, Intravenous; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Organoplatinum Compounds; Taxoids; Young Adult | 2015 |
[Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Chronotherapy; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome | 2015 |
A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cetuximab; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Taxoids; Young Adult | 2016 |
An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclobutanes; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Taxoids | 2016 |
[Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mucositis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prospective Studies; Remission Induction; Taxoids; Young Adult | 2009 |
Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Palliative Care; Quality of Life; Taxoids; Treatment Failure | 2011 |
40 other study(ies) available for docetaxel anhydrous and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Gemcitabine; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies | 2022 |
Effects of combination docetaxel with NO treatment to enhance the anti-nasopharyngeal carcinoma efficiency in vitro and in vivo.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Mice; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Xenograft Model Antitumor Assays | 2022 |
Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum | 2023 |
Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma.
Topics: Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms | 2023 |
Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gemcitabine; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2019 |
Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Bone Morphogenetic Protein Receptors; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Female; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Prognosis; RNA, Circular; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; China; Cisplatin; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gemcitabine; Humans; Induction Chemotherapy; Male; Markov Chains; Middle Aged; Multicenter Studies as Topic; Nasopharyngeal Carcinoma; Randomized Controlled Trials as Topic; Young Adult | 2020 |
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; China; Cisplatin; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Treatment Outcome | 2020 |
Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate | 2020 |
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Pilot Projects; Progression-Free Survival; Retrospective Studies; Young Adult | 2021 |
Docetaxel exposure and hematological toxicity in Chinese patients with locally advanced/metastatic nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; China; Docetaxel; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Taxoids | 2021 |
The change in tumor volume after induction chemotherapy with docetaxel plus cisplatin in 259 nasopharyngeal carcinoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Retrospective Studies; Tumor Burden | 2021 |
Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Propensity Score; Retrospective Studies | 2022 |
Survival benefit of adding docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy to concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma with nodal Stage N2-3.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Retrospective Studies; Survival Analysis; Taxoids | 2017 |
Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area.
Topics: Adult; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Neutropenia; Prognosis; Survival Analysis; Taxoids; Young Adult | 2018 |
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
Topics: Animals; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Carriers; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Transplantation, Heterologous | 2017 |
A Retrospective Study to Compare Five Induction Chemotherapy Regimens Prior to Radiotherapy in the Reduction of Regional Lymph Node Size in Patients with Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Carcinoma; Chemoradiotherapy; China; Cisplatin; Disease-Free Survival; Docetaxel; Endostatins; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy; Retrospective Studies; Taxoids | 2018 |
Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Radiation; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Diseases; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, High-Energy; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Ulcer | 2018 |
Topics: Antineoplastic Combined Chemotherapy Protocols; Computational Biology; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Profiling; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Matrix Metalloproteinase 2; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Promoter Regions, Genetic; rab GTP-Binding Proteins; Sequence Analysis, DNA; Tissue Inhibitor of Metalloproteinase-2 | 2018 |
Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Edema; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Incidence; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Necrosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Temporal Lobe | 2018 |
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Cell Line, Tumor; Cisplatin; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Herpesvirus 4, Human; Humans; Liposomes; Male; Middle Aged; Nasopharyngeal Carcinoma; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids | 2018 |
Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.
Topics: 3T3 Cells; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Drug Carriers; Drug Delivery Systems; Gene Transfer Techniques; Genetic Therapy; Glutathione; Graphite; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; RNA, Small Interfering; Transferrin | 2019 |
Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; DNA-Binding Proteins; Docetaxel; Female; Genotype; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Polymorphism, Single Nucleotide; Radiation Tolerance; Taxoids; Treatment Outcome; X-ray Repair Cross Complementing Protein 1 | 2016 |
Prediction of the response to docetaxel-based chemotherapy for locoregionally advanced nasopharyngeal carcinoma: the role of double-phase (99m)Tc-MIBI SPECT/CT.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radiopharmaceuticals; Taxoids; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2014 |
Prognostic factors on overall survival of newly diagnosed metastatic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neck; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Radiotherapy, Conformal; Survival Rate; Taxoids; Young Adult | 2014 |
Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Oxaliplatin; Survival Rate; Taxoids; Treatment Outcome; Young Adult | 2015 |
Olfactory event-related potentials: a new approach for the evaluation of olfaction in nasopharyngeal carcinoma patients treated with chemo-radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Evoked Potentials; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Olfaction Disorders; Radiotherapy, Intensity-Modulated; Smell; Surveys and Questionnaires; Taxoids | 2016 |
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
Topics: Animals; Apoptosis; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Folic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Tissue Distribution; Transfection | 2016 |
Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphopyruvate Hydratase; Proteomics; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Taxoids | 2016 |
Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy, Intensity-Modulated; Survival Rate; Taxoids; Treatment Outcome | 2017 |
Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro.
Topics: Autophagy; Carcinoma; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Docetaxel; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; High Mobility Group Proteins; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Neoplasm Invasiveness; Protein Serine-Threonine Kinases; Proto-Oncogene Protein c-ets-1; Proto-Oncogene Proteins; Signal Transduction; Taxoids; Transcriptional Elongation Factors | 2016 |
Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Prognosis; Taxoids | 2016 |
Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease Progression; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Treatment Outcome; Young Adult | 2017 |
Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Prognosis; Taxoids; Treatment Outcome; Young Adult | 2017 |
Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma; Cell Differentiation; Cell Line; Cell Separation; Cisplatin; Docetaxel; Humans; Hyaluronan Receptors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; Taxoids | 2011 |
Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Leucovorin; Male; Methotrexate; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Retrospective Studies; Taxoids | 2012 |
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
Topics: Adult; Aged; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Intensity-Modulated; Taxoids; Treatment Outcome | 2013 |
Concurrent weekly docetaxel chemotherapy in combination with radiotherapy for stage III and IVA-B nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Staging; Radiotherapy Dosage; Retrospective Studies; Taxoids; Young Adult | 2012 |